Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?

[1]  B. Michalski,et al.  The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease , 2001, Molecular and Cellular Neuroscience.

[2]  N. Seidah,et al.  Biosynthesis and Post-translational Processing of the Precursor to Brain-derived Neurotrophic Factor* , 2001, The Journal of Biological Chemistry.

[3]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[4]  R. Holsinger,et al.  Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. , 2000, Brain research. Molecular brain research.

[5]  E. Tolosa,et al.  BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. , 1999, Journal of neuropathology and experimental neurology.

[6]  E. Mufson,et al.  Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases , 1999, Progress in Neurobiology.

[7]  L. Olson,et al.  TrkB and Neurotrophin-4 Are Important for Development and Maintenance of Sympathetic Preganglionic Neurons Innervating the Adrenal Medulla , 1998, The Journal of Neuroscience.

[8]  B. Winblad,et al.  Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[9]  D. Turner,et al.  In vitro survival and differentiation of neurons derived from epidermal growth factor-responsive postnatal hippocampal stem cells: inducing effects of brain-derived neurotrophic factor. , 1998, Journal of neurobiology.

[10]  M. Barbacid,et al.  Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR. , 1998, Developmental biology.

[11]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[12]  H. Phillips,et al.  Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits , 1997, The Journal of Neuroscience.

[13]  J. Siuciak,et al.  Effects of BDNF Infusion on the Regulation of TrkB Protein and Message in Adult Rat Brain , 1997, Experimental Neurology.

[14]  S. Tsuji,et al.  Regional specificity of alterations in NGF, BDNF and NT‐3 levels in Alzheimer's disease , 1996, Neuroreport.

[15]  H. Thoenen,et al.  Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4 , 1996, The European journal of neuroscience.

[16]  M. Pelleymounter,et al.  Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. , 1996, The Journal of pharmacology and experimental therapeutics.

[17]  L. Arsenault,et al.  The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  N. Seidah,et al.  Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases , 1996, FEBS letters.

[19]  J. Bizon,et al.  NGF mRNA is expressed by GABAergic but not cholinergic neurons in rat basal forebrain , 1995, The Journal of comparative neurology.

[20]  E. Schuman,et al.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus , 1995, Science.

[21]  E. Castrén,et al.  Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus , 1995, Neuroscience.

[22]  Stanley J. Wiegand,et al.  Neurotrophic factors: from molecule to man , 1994, Trends in Neurosciences.

[23]  I. Black,et al.  Neurotrophin-3 selectively increases cultured Purkinje cell survival. , 1994, Neuroreport.

[24]  D. Price,et al.  Highly selective effects of nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 on intact and injured basal forebrain magnocellular neurons , 1994, The Journal of comparative neurology.

[25]  E. Jones,et al.  Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease , 1994, Neuroscience.

[26]  Marlies Knipper,et al.  Positive Feedback between Acetylcholine and the Neurotrophins Nerve Growth Factor and Brain‐derived Neurotrophic Factor in the Rat Hippocampus , 1994, The European journal of neuroscience.

[27]  M E Greenberg,et al.  Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.

[28]  T. Hasegawa,et al.  Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats , 1993, Neuroscience.

[29]  C. Altar,et al.  Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  O. Lindvall,et al.  Coexpression of neurotrophins and their receptors in neurons of the central nervous system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Black,et al.  Differential Actions of Neurotrophins in the Locus Coeruleus and Basal Forebrain , 1993, Experimental Neurology.

[32]  F. Hefti,et al.  Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  Stanley J. Wiegand,et al.  The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons , 1992, Neuron.

[34]  Takeda Masatoshi,et al.  Change in the cttoskeletal system in fibroblasts from patients with familial Alzheimer's disease , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  Steven A. Johnson,et al.  BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.

[36]  M. Takeda,et al.  Study of cytoskeletal proteins in fibroblasts cultured from familial Alzheimer's disease , 1991, Acta neurologica Scandinavica.

[37]  D. Price,et al.  Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat , 1991, Experimental Neurology.

[38]  H. Phillips,et al.  Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. , 1990, Science.

[39]  Yves-Alain Barde,et al.  Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture , 1990, Neuron.

[40]  Y. Barde,et al.  Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.

[41]  C. Dreyfus.  Effects of nerve growth factor on cholinergic brain neurons. , 1989, Trends in pharmacological sciences.

[42]  S. Hunt,et al.  Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. , 1986, Brain research.

[43]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[44]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[45]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[46]  S H Appel,et al.  A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease , 1981, Annals of neurology.

[47]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[48]  L C Katz,et al.  Neurotrophins and synaptic plasticity. , 1999, Annual review of neuroscience.

[49]  M. Takeda,et al.  Change in the cytoskeletal system in fibroblasts from patients with familial Alzheimer's disease. , 1992, Progress in neuro-psychopharmacology & biological psychiatry.